Philip Agop Philip, MD, PhD, FRCP of Karmanos Cancer Institute gives his perspective on how to use both TAS-102 and regorafenib for patients with metastatic colorectal cancer at the 2017 Gastrointestinal Cancers Symposium (Annual Meeting GI) in San Francisco, CA.
How to Use Both TAS-102 and Regorafenib in Metastatic CRC Patients
